Subcutaneous IGF-1 is not beneficial in 2-year ALS trial (Q24651555)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
scientific article

    Statements

    Subcutaneous IGF-1 is not beneficial in 2-year ALS trial (English)
    0 references
    E J Sorenson
    0 references
    A J Windbank
    0 references
    J N Mandrekar
    0 references
    W R Bamlet
    0 references
    S H Appel
    0 references
    C Armon
    0 references
    P E Barkhaus
    0 references
    P Bosch
    0 references
    K Boylan
    0 references
    W S David
    0 references
    E Feldman
    0 references
    J Glass
    0 references
    J Katz
    0 references
    W King
    0 references
    C A Luciano
    0 references
    L F McCluskey
    0 references
    S Nash
    0 references
    D S Newman
    0 references
    R M Pascuzzi
    0 references
    E Pioro
    0 references
    L J Sams
    0 references
    S Scelsa
    0 references
    E P Simpson
    0 references
    S H Subramony
    0 references
    E Tiryaki
    0 references
    C A Thornton
    0 references
    25 November 2008
    0 references
    0 references
    71
    0 references
    22
    0 references
    1770-5
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit